We are pleased to announce our upcoming event in collaboration with UZ Gent Health, Innovation and Research Institute (HIRUZ), Drug Research Unit Ghent (D.R.U.G.) and Safepedrug Clinical Trial Unit (SPD_CTU).
With this event we want to meet with our stakeholders and present the infrastructure and experience in clinical trials and drug research at Ghent University Hospital.
Doelgroep
For: physicians, researchers, study coordinators, pharma industry, other professionals interested in drug development
Programma
Thursday 25 April 2024
- 12.00 | Registration with light lunch
- 13.00 | Welcome | Piet Hoebeke, Dean of the Faculty of Medicine and Health Sciences, Ghent University
- 13.15 | New directions/new mode of actions studied in phase I trials | Dr Rachel Galot, Cliniques Universitaires Saint-Luc
- 13.45 | Statistical interpretation of clinical trial data | Dr Alexander Decruyenaere, Ghent University Hospital
- 14.15 | Challenges in development of CAR-T therapies in pediatrics | Prof. Dr Claudia Rössig, University Hospital Münster
- 14.45 | Melanoma: more progress, more hope, more time | Dr Celine Jacobs, Ghent University Hospital
- 15.15 | Tea break & visit exhibitors
- 15.45 | Challenges in performing clinical trials in low incidence disease | Prof. Dr Sylvie Rottey and Dr Levi Hoste, Ghent University Hospital
- 16.15 | Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM | Prof. Dr Ina Oehme, DKFZ Heidelberg
- 16.45 | Closing word | Philippe Van Rompaey, Ghent University Hospital
- 17.15 | Networking drink
Friday 26 April 2024
- 08.30 | Registration with coffee
- 09.00 | Welcome | Prof. Dr Frank Vermassen, Chief Physician Ghent University Hospital
- 09.15 | Clinical Trials in Rare Diseases | Dr Eva Degraeuwe, Ghent University and Ghent University Hospital
- 09.45 | CHIM story – human challenge trials | Prof. Pierre Van Damme, University of Antwerp
- 10.15 | First learnings from the European clinical trial regulation and its impact on research in Belgium | Tim Weglewski, IQVIA
- 10.45 | Coffee break & visit exhibitors
- 11.30 | Gene therapies in ophthalmology | Prof. Dr Bart Leroy, Ghent University Hospital
- 12.00 | Patients as partners: the power of a Patient Advisory Board for clinical research (PAWO) |
Wendy Van de Velde, PAWO, Ghent University Hospital (presentation in Dutch) - 12.30 | Networking lunch & visit exhibitors
- 13.30 | Leveraging RCTs to unravel fundamental biology: lessons from COVID-19 | Dr Karel Van Damme, Ghent University, IRC
- 14.00 | Future GMP facility for Gene and Cell therapy at U(Z) Gent | Dr Tim Desmet, Ghent University
- 14.30 | Sarcoma models database/website | Prof. Dr Olivier De Wever, Ghent University
- 15.00 | Cochrane reviews: content – method – purpose. Post marketing surveillance | Dr Ellen Van Leeuwen, Ghent University
- 15.30 | Closing word | Prof. Dr Sylvie Rottey
- 16.00 | Farewell reception
Praktische informatie
Practical information
- Thursday 25 and Friday 26 April 2024
- Zebrastraat, Gustaaf Callierlaan 231, 9000 Gent | www.zebrastraat.be
- Register online
- For further information, please contact: info@drugdevsympogent.be
RIZIV / INAMI accreditation has been requested
Special thanks to Kinderkankerfonds
Sponsors
- Bristol Myers Squibb Belgium SA/NV
- MSD Belgium
- Astellas Pharma BV
- Roche NV/SA